Radiation for Triple-Negative Breast Cancer: 84 Real Stories

84 stories match breast cancer, triple-negative and radiation. 82 of them mention surgery.

A patient, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

Triple-Negative Breast Cancer Recurring in Groin Lymph Nodes

Patient Info: Anonymized, Female | Stage IV

Biomarkers: ER-negative; PR-negative; HER2-negative

Metastatic Site: right inguinal lymph node; right iliac/pelvic lymph…

Her condition deteriorated after 3 cycles of palliative capecitabine. She developed vomiting, headache and seizures concerning for brain metastases and died about 4 months after the groin metastasis was detected.

PubMed Central
OutcomeIn Memory
Sandra, who was diagnosed with Breast CancerBreast Cancer

Triple-Negative Breast Cancer: Sandra's Survivor Story

Patient Info: Sandra Monsonís, Female, 40s

Biomarkers: Triple-negative breast cancer; BRCA-positive

As of November 2021, Sandra felt healthy and happy after treatment for triple-negative breast cancer, BRCA-positive testing, double mastectomy, implant complication care, external prosthesis, and ovary removal to reduce future cancer risk.

MatchTrial Historias Reales
OutcomeSurvivorship / Completed Treatment
Muriel, who was diagnosed with Breast CancerBreast Cancer

BRCA1 Breast Cancer: Muriel's Survivor Story

Patient Info: Muriel Verger, Female, Under 40

Biomarkers: BRCA1 mutation

As of October 2021, Muriel described having completed about 9 months of treatment for triple-negative breast cancer diagnosed in 2015 and focused her message on survivorship, body image, and early detection.

YouTube (FR search)
OutcomeSurvivorship / Completed Treatment
A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

Triple-negative breast cancer first discovered through a duodenal metastasis

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: ER-negative; PR-negative; HER2-negative; CK7-positive; GATA3-positive; vimentin-positive; CDX2-negative; CK20-negative., triple negative

Metastatic Site: duodenum

She died two days after choosing comfort-focused care, following rapid decline from metastatic triple-negative breast cancer with duodenal involvement and small-bowel obstruction.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Breast CancerBreast Cancer

Silicone lymphadenopathy after treatment for recurrent triple-negative breast cancer

Patient Info: Anonymized, Female, 50s

Biomarkers: Triple-negative; BRCA1-negative; BRCA2-negative; latest recurrence Ki-67 60%–70%.

At the May 2020 follow-up, biopsies confirmed silicone-related lymph-node changes rather than cancer, and imaging showed no recurrent disease while six-monthly surveillance continued.

PubMed Central
OutcomeCancer-Free / NED
Eva, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Triple-Negative Breast Cancer: Eva's Patient Story

Patient Info: Eva Joseph | Stage IV

Biomarkers: Triple-negative

Metastatic Site: lungs, sternum

On ongoing atezolizumab plus nab-paclitaxel, Eva’s lung and sternum tumors became very small and were being kept at bay while she felt well enough to enjoy short trips.

AACR
OutcomeResponding Well
A patient, who was diagnosed with Stage III Invasive Ductal CarcinomaBreast Cancer

Dramatic chemotherapy response in stage IIIB triple-negative breast cancer

Patient Info: Anonymized, Female, 40s | Stage III

Biomarkers: ER-negative; PR-negative; HER2-negative; BRCA1-negative; BRCA2-negative; germline FLCN c.1285delC associated with Birt-Hogg-Dubé syndrome; tumor TP53 p.T150fs.

Eighteen months after surgery, she had no recurrence following a dramatic chemotherapy response, bilateral mastectomy, chest-wall radiation, and adjuvant capecitabine.

PubMed Central
OutcomeCancer-Free / NED
Mary, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Triple-Negative Breast Cancer: Mary's Survivor Story

Patient Info: Mary, Female | Stage III

Biomarkers: ER-negative; PR-negative; HER2-negative., triple negative

Mary completed treatment, was declared cancer-free in February 2025, and was in remission without ongoing medication.

Our Cancer Stories
OutcomeCancer-Free / NED
Bridgette, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Triple-Negative Breast Cancer: Bridgette's Survivor Story

Patient Info: Bridgette, Female, 60s | Stage III

Biomarkers: Triple-negative breast cancer

Bridgette completed treatment and described herself as being in remission and free of cancer. Fear of recurrence continued to affect her survivorship.

Our Cancer Stories
OutcomeCancer-Free / Remission
A patient, who was diagnosed with Stage III Breast CancerBreast Cancer

Triple-negative glycogen-rich clear cell carcinoma of the breast: chemotherapy, mastectomy, and radiation

Patient Info: Anonymized, Female, 50s | Stage III

Biomarkers: Triple-negative breast cancer with glycogen-rich clear cell features; pathology stains supported breast carcinoma.

Asymptomatic and disease-free 14 months after surgery, additional chemotherapy, and 50 Gy radiotherapy for T4N0M0 triple-negative glycogen-rich clear cell breast carcinoma.

PubMed Central
OutcomeCancer-Free / NED